Annual EBITDA
-$96.45M$541.70K+0.56%
Summary
- Current Value
- As of today, OCS annual EBITDA is -$96.45M, up +0.56% on
- Historical Performance
- OCS annual EBITDA is down -569.40% over the past 3 years, and down -657.71% over the past 5 years
- All-Time High Comparison
- OCS annual EBITDA is currently -657.71% below its historical high of -$12.73M set on
- 3-Year Low Comparison
- OCS annual EBITDA is +0.56% above its 3-year low of -$96.99M reached on
- Sector Comparison
- OCS annual EBITDA is higher than 17.90% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$96.45M | +0.6% | -569.4% | -657.7% | -657.7% | |
| Quarterly EBITDA | -$25.48M | -21.1% | -10000.0% | -10000.0% | -10000.0% | |
| TTM EBITDA | -$92.73M | -19.5% | -10000.0% | -10000.0% | -10000.0% | |
| Price | $20.97 | +15.1% | +108.0% | – | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $0.00 | 0.0% | 0.0% | – | – | |
| Annual EPS | -$2.41 | +27.1% | -2327.8% | -397.4% | -397.4% | |
| Annual EBIT | -$96.91M | +0.4% | -560.8% | -647.1% | -647.1% | |
| Annual Net Income | -$97.40M | +1.4% | -6686.9% | -514.0% | -514.0% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$33.45M | N/A | -188.3% |
| 5Y | -$12.73M | N/A | -657.7% |
| All | -$12.73M | -657.7% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$96.99M | +0.6% | |
| 5Y | -$96.99M | +0.6% | |
| All | -$96.99M | +0.6% |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$96.45M | +0.6% | |
| -$96.99M | -190.0% | |
| -$33.45M | -132.2% |
| Year | Value | Change |
|---|---|---|
| -$14.41M | -13.2% | |
| -$12.73M | - |
FAQ
What is the current annual EBITDA of OCS?
As of today, OCS annual EBITDA is -$96.45M
What is 1-year change in OCS annual EBITDA?
OCS annual EBITDA is up +0.56% year-over-year
What is 3-year change in OCS annual EBITDA?
OCS annual EBITDA is down -569.40% over the past 3 years
How far is OCS annual EBITDA from its all-time high?
OCS annual EBITDA is currently -657.71% below its historical high of -$12.73M set on December 1, 2020
How does OCS annual EBITDA rank versus sector peers?
OCS annual EBITDA is higher than 17.90% of companies in Healthcare sector
When is OCS next annual earnings release?
The next annual earnings release for OCS is on
Quarterly EBITDA
-$25.48M$153.00K-0.60%
Summary
- Current Value
- As of today, OCS quarterly EBITDA is -$25.48M, down -0.60% on
- Historical Performance
- OCS quarterly EBITDA is down -21.10% year-over-year, and down -11181.34% over the past 3 years
- All-Time High Comparison
- OCS quarterly EBITDA is currently -11181.34% below its historical high of $229.90K set on
- 3-Year Low Comparison
- OCS quarterly EBITDA is at its 3-year low
- Sector Comparison
- OCS quarterly EBITDA is higher than 16.98% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$25.48M | -0.6% | -21.1% | -10000.0% | -10000.0% | |
| Annual EBITDA | -$96.45M | – | +0.6% | -569.4% | -657.7% | |
| TTM EBITDA | -$92.73M | -5.0% | -19.5% | -10000.0% | -10000.0% | |
| Price | $20.97 | +10.0% | +15.1% | +108.0% | – | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $0.00 | 0.0% | 0.0% | – | 0.0% | |
| Quarterly EPS | -$0.40 | +31.5% | +27.8% | -100.0% | -2613.8% | |
| Quarterly EBIT | -$25.66M | -0.8% | -21.2% | -100.0% | -10000.0% | |
| Quarterly Net Income | -$21.06M | +31.4% | +9.6% | – | -8365.8% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$19.54M | N/A | -30.4% |
| 3Y | $68.00K | >-9999.0% | |
| 5Y | $229.90K | >-9999.0% | |
| All | $229.90K | >-9999.0% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$25.48M | at low | |
| 3Y | -$25.48M | at low | |
| 5Y | -$25.48M | at low | |
| All | -$25.48M | at low |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of OCS?
As of today, OCS quarterly EBITDA is -$25.48M
What is OCS quarterly EBITDA most recent change?
OCS quarterly EBITDA was down -0.60% on September 30, 2025
What is 1-year change in OCS quarterly EBITDA?
OCS quarterly EBITDA is down -21.10% year-over-year
How far is OCS quarterly EBITDA from its all-time high?
OCS quarterly EBITDA is currently -11181.34% below its historical high of $229.90K set on September 30, 2022
How does OCS quarterly EBITDA rank versus sector peers?
OCS quarterly EBITDA is higher than 16.98% of companies in Healthcare sector
When is OCS next earnings release?
The next earnings release for OCS is on
TTM EBITDA
-$92.73M$4.44M-5.03%
Summary
- Current Value
- As of today, OCS TTM EBITDA is -$92.73M, down -5.03% on
- Historical Performance
- OCS TTM EBITDA is down -19.52% year-over-year, and down -58778.73% over the past 3 years
- All-Time High Comparison
- OCS TTM EBITDA is currently -20602.76% below its historical high of $452.30K set on
- 3-Year Low Comparison
- OCS TTM EBITDA is at its 3-year low
- Sector Comparison
- OCS TTM EBITDA is higher than 18.07% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$92.73M | -5.0% | -19.5% | -10000.0% | -10000.0% | |
| Annual EBITDA | -$96.45M | – | +0.6% | -569.4% | -657.7% | |
| Quarterly EBITDA | -$25.48M | -0.6% | -21.1% | -10000.0% | -10000.0% | |
| Price | $20.97 | +10.0% | +15.1% | +108.0% | – | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $0.00 | 0.0% | 0.0% | – | 0.0% | |
| TTM EPS | -$2.52 | +5.8% | -25.1% | -9059.3% | -10000.0% | |
| TTM EBIT | -$93.34M | -5.0% | -19.7% | -10000.0% | -10000.0% | |
| TTM Net Income | -$121.39M | +1.8% | -54.0% | – | -10000.0% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$83.26M | N/A | -11.4% |
| 3Y | $452.30K | >-9999.0% | |
| 5Y | $452.30K | >-9999.0% | |
| All | $452.30K | >-9999.0% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$92.73M | at low | |
| 3Y | -$92.73M | at low | |
| 5Y | -$92.73M | at low | |
| All | -$92.73M | at low |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of OCS?
As of today, OCS TTM EBITDA is -$92.73M
What is OCS TTM EBITDA most recent change?
OCS TTM EBITDA was down -5.03% on September 30, 2025
What is 1-year change in OCS TTM EBITDA?
OCS TTM EBITDA is down -19.52% year-over-year
How far is OCS TTM EBITDA from its all-time high?
OCS TTM EBITDA is currently -20602.76% below its historical high of $452.30K set on March 31, 2023
How does OCS TTM EBITDA rank versus sector peers?
OCS TTM EBITDA is higher than 18.07% of companies in Healthcare sector
When is OCS next earnings release?
The next earnings release for OCS is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- OCS Official Website oculis.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1953530/000095017025037224/0000950170-25-037224-index.htm
- OCS Profile on Yahoo Finance finance.yahoo.com/quote/OCS
- OCS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ocs